Ausgabe 5/2024
Inhalt (15 Artikel)
PMDA regulatory update on approval of new drugs and revisions of precautions; approval of talazoparib tosilate for prostate and breast cancer, and luspatercept for myelodysplastic syndrome in Japan
Noriomi Matsumura, Masaki Mandai
Bridging horizons beyond CIRCULATE-Japan: a new paradigm in molecular residual disease detection via whole genome sequencing-based circulating tumor DNA assay
Tadayoshi Hashimoto, Yoshiaki Nakamura, Eiji Oki, Shin Kobayashi, Junichiro Yuda, Taro Shibuki, Hideaki Bando, Takayuki Yoshino
Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2
Yoshinori Kikuchi, Hideaki Shimada, Fumiyuki Yamasaki, Taku Yamashita, Koji Araki, Kohei Horimoto, Satoshi Yajima, Masakazu Yashiro, Keigo Yokoi, Haruhiko Cho, Takuya Ehira, Kazunari Nakahara, Hiroshi Yasuda, Kazutoshi Isobe, Tetsu Hayashida, Shingo Hatakeyama, Koichiro Akakura, Daisuke Aoki, Hiroyuki Nomura, Yuji Tada, Yuki Yoshimatsu, Hayato Miyachi, Chiaki Takebayashi, Ichiro Hanamura, Hiroyuki Takahashi
Effectiveness and safety of primary prophylaxis with G-CSF after induction therapy for acute myeloid leukemia: a systematic review and meta-analysis of the clinical practice guidelines for the use of G-CSF 2022 from the Japan society of clinical oncology
Tomoya Maeda, Yuho Najima, Yutaro Kamiyama, Shinji Nakao, Yukinori Ozaki, Hiroshi Nishio, Kenji Tsuchihashi, Eiki Ichihara, Yuji Miumra, Makoto Endo, Dai Maruyama, Tatsuhiro Yoshinami, Nobuyuki Susumu, Munetaka Takekuma, Takashi Motohashi, Mamoru Ito, Eishi Baba, Nobuaki Ochi, Toshio Kubo, Keita Uchino, Takahiro Kimura, Shinobu Tamura, Hitomi Nishimoto, Yasuhisa Kato, Atsushi Sato, Toshimi Takano, Shingo Yano
Effectiveness and safety of primary prophylaxis of granulocyte colony-stimulating factor during dose-dense chemotherapy for urothelial cancer: Clinical Practice Guidelines for the Use of G-CSF 2022
Keita Uchino, Shingo Tamura, Shoji Kimura, Keisuke Shigeta, Takahiro Kimura, Yukinori Ozaki, Hiroshi Nishio, Kenji Tsuchihashi, Eiki Ichihara, Makoto Endo, Shingo Yano, Dai Maruyama, Tetsuhiro Yoshinami, Nobuyuki Susumu, Munetaka Takekuma, Takashi Motohashi, Mamoru Ito, Eishi Baba, Nobuaki Ochi, Toshio Kubo, Yutaro Kamiyama, Shinji Nakao, Shinobu Tamura, Hitomi Nishimoto, Yasuhisa Kato, Atsushi Sato, Toshimi Takano, Yuji Miura
Optimal timing of prophylactic pegylated G-CSF after chemotherapy administration for patients with cancer: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022
Yukinori Ozaki, Takamichi Yokoe, Tetsuhiro Yoshinami, Kazuki Nozawa, Hiroshi Nishio, Kenji Tsuchihashi, Eiki Ichihara, Yuji Miura, Makoto Endo, Shingo Yano, Dai Maruyama, Nobuyuki Susumu, Munetaka Takekuma, Takashi Motohashi, Mamoru Ito, Eishi Baba, Nobuaki Ochi, Toshio Kubo, Keita Uchino, Takahiro Kimura, Yutaro Kamiyama, Shinji Nakao, Shinobu Tamura, Hitomi Nishimoto, Yasuhisa Kato, Atsushi Sato, Toshimi Takano
Effectiveness and safety of primary prophylaxis of G-CSF during chemotherapy for prostate cancer, Japanese clinical guideline for appropriate use of G-CSF: clinical practice guidelines for the use of G-CSF 2022
Shoji Kimura, Keisuke Shigeta, Shingo Tamura, Keita Uchino, Takahiro Kimura, Yukinori Ozaki, Hiroshi Nishio, Kenji Tsuchihashi, Eiki Ichihara, Makoto Endo, Shingo Yano, Dai Maruyama, Tetsuhiro Yoshinami, Nobuyuki Susumu, Munetaka Takekuma, Takashi Motohashi, Mamoru Ito, Eishi Baba, Nobuaki Ochi, Toshio Kubo, Yutaro Kamiyama, Shinji Nakao, Shinobu Tamura, Hitomi Nishimoto, Yasuhisa Kato, Atsushi Sato, Toshimi Takano, Yuji Miura
Current status of head and neck sarcomas in Japan in 2016–2019: an analysis using the national cancer registry
Ryoko Rikitake, Yu Mizushima, Seiichi Yoshimoto, Takahiro Higashi, Tomoyuki Satake, Chigusa Morizane, Akira Kawai
An approach for improvement of the accuracy of cancer gene panel testing
Kiyomi Imoto, Hiroyuki Yamamoto, Chie Ohkawa, Naoki Shimada, Ryo Ikuzawa, Hiroyuki Takeda, Tatsuru Ohhara, Yasuyuki Kojima, Naoki Furuya, Ai Motoyoshi, Ohsuke Migita, Asami Kuga, Takayuki Keira, Hirotake Wakamatsu, Tomoo Sato, Nobuyuki Oike, Junki Koike, Yoshihisa Yamano, Yu Sunakawa
Lymphatic drainage patterns of malignant skin tumors in the head and neck region: a single-center retrospective study
Takuya Nishio, Taku Maeda, Kosuke Ishikawa, Naoki Murao, Kanako Fuyama, Yuhei Yamamoto, Toshihiko Hayashi
Sarcopenia is associated with leukopenia in urothelial carcinoma patients who receive tislelizumab combined with gemcitabine and cisplatin therapy
Zhimin Gao, Yubin Pang, Xu Qin, Gang Li, Zewei Wang, Lei Zhang, Junqi Wang, Nienie Qi, Hailong Li
Peripheral neuropathy and nerve electrophysiological changes with enfortumab vedotin in patients with advanced urothelial carcinoma: a prospective multicenter cohort study
Rikiya Taoka, Masaki Kamada, Kazuyoshi Izumi, Ryuta Tanimoto, Kei Daizumoto, Yushi Hayashida, Katsutoshi Uematsu, Hironobu Arai, Takeshi Sano, Ryoichi Saito, Hiromi Hirama, Toshihiro Kobayashi, Tomoko Honda, Yu Osaki, Yohei Abe, Hirohito Naito, Yoichiro Tohi, Yuki Matsuoka, Takuma Kato, Homare Okazoe, Nobufumi Ueda, Mikio Sugimoto
Association between comorbidities and survival in patients with metastatic urothelial carcinoma treated with pembrolizumab
Masaki Hashimoto, Wataru Fukuokaya, Takafumi Yanagisawa, Shutaro Yamamoto, Yuhei Koike, Yu Imai, Kosuke Iwatani, Hajime Onuma, Kagenori Ito, Fumihiko Urabe, Shunsuke Tsuzuki, Shoji Kimura, Yu Oyama, HIrokazu Abe, Jun Miki, Takahiro Kimura
MRI-based volumetric tumor parameters before and during chemoradiation predict tumor recurrence and patient survival in locally advanced cervical cancer: a subgroup analysis of a phase II prospective trial
Han Byul Kang, Sung Hwan Kim, Joo Hwan Lee, Hyo Chun Lee, Nam Kyu Kang, Jong Hoon Lee
Magnesium supplementation therapy to prevent cisplatin-induced acute nephrotoxicity in pediatric cancer: a randomized phase-2 trial
Motohiro Matsui, Atsushi Makimoto, Motoaki Chin, Katsuyoshi Koh, Masako Tomotsune, Tetsuji Kaneko, Yoshihiko Morikawa, Riku Hamada, Yuki Yuza